Report Detail
Global Huntington's Disease Therapeutics Market Research Report 2019
- RnM3123419 |
- 14 March, 2019 |
- Global |
- 93 Pages |
- QYResearch |
- Pharma & Healthcare
Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease.
The demand for Huntington’s disease (HD) therapeutics as one of the primary growth factors for the Huntington’s disease therapeutics market. HD is equally prevalent in both males and females and affects people irrespective of their ethnicity. The disease symptoms may appear anytime in the individual’s life and the etiology is genetic. The person who inherits the mutated genes from their affected parents will probably suffer from the disease sometime in their lifetime.
The Americas is witnessing increasing incidences of HD. The availability of increased patient pool and the rise in government initiatives boost the research and development of novel therapeutics for the treatment of HD. The rising investments towards the launch of new drugs for the treatment of chorea will positively influence the growth of the Huntington’s disease therapeutics market in this region.
The global Huntington's Disease Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Huntington's Disease Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Huntington's Disease Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
F. Hoffmann-La Roche
H. Lundbeck
Prana Biotechnology
Teva Pharmaceutical Industries
Horizon Pharma
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Antidopaminergics
Anticonvulsants
Antipsychotics
Antidepressants
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Table of Contents
Executive Summary
1 Huntington's Disease Therapeutics Market Overview
- 1.1 Product Overview and Scope of Huntington's Disease Therapeutics
- 1.2 Huntington's Disease Therapeutics Segment by Type
- 1.2.1 Global Huntington's Disease Therapeutics Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Antidopaminergics
- 1.2.3 Anticonvulsants
- 1.2.4 Antipsychotics
- 1.2.5 Antidepressants
- 1.3 Huntington's Disease Therapeutics Segment by Application
- 1.3.1 Huntington's Disease Therapeutics Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Diagnostic Centers
- 1.4 Global Huntington's Disease Therapeutics Market by Region
- 1.4.1 Global Huntington's Disease Therapeutics Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Huntington's Disease Therapeutics Market Size
- 1.5.1 Global Huntington's Disease Therapeutics Revenue (2014-2025)
- 1.5.2 Global Huntington's Disease Therapeutics Production (2014-2025)
2 Global Huntington's Disease Therapeutics Market Competition by Manufacturers
- 2.1 Global Huntington's Disease Therapeutics Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Huntington's Disease Therapeutics Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Huntington's Disease Therapeutics Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Huntington's Disease Therapeutics Production Sites, Area Served, Product Types
- 2.5 Huntington's Disease Therapeutics Market Competitive Situation and Trends
- 2.5.1 Huntington's Disease Therapeutics Market Concentration Rate
- 2.5.2 Huntington's Disease Therapeutics Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Huntington's Disease Therapeutics Production Market Share by Regions
- 3.1 Global Huntington's Disease Therapeutics Production Market Share by Regions
- 3.2 Global Huntington's Disease Therapeutics Revenue Market Share by Regions (2014-2019)
- 3.3 Global Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Huntington's Disease Therapeutics Production
- 3.4.1 North America Huntington's Disease Therapeutics Production Growth Rate (2014-2019)
- 3.4.2 North America Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Huntington's Disease Therapeutics Production
- 3.5.1 Europe Huntington's Disease Therapeutics Production Growth Rate (2014-2019)
- 3.5.2 Europe Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Huntington's Disease Therapeutics Production (2014-2019)
- 3.6.1 China Huntington's Disease Therapeutics Production Growth Rate (2014-2019)
- 3.6.2 China Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Huntington's Disease Therapeutics Production (2014-2019)
- 3.7.1 Japan Huntington's Disease Therapeutics Production Growth Rate (2014-2019)
- 3.7.2 Japan Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Huntington's Disease Therapeutics Consumption by Regions
- 4.1 Global Huntington's Disease Therapeutics Consumption by Regions
- 4.2 North America Huntington's Disease Therapeutics Consumption (2014-2019)
- 4.3 Europe Huntington's Disease Therapeutics Consumption (2014-2019)
- 4.4 China Huntington's Disease Therapeutics Consumption (2014-2019)
- 4.5 Japan Huntington's Disease Therapeutics Consumption (2014-2019)
5 Global Huntington's Disease Therapeutics Production, Revenue, Price Trend by Type
- 5.1 Global Huntington's Disease Therapeutics Production Market Share by Type (2014-2019)
- 5.2 Global Huntington's Disease Therapeutics Revenue Market Share by Type (2014-2019)
- 5.3 Global Huntington's Disease Therapeutics Price by Type (2014-2019)
- 5.4 Global Huntington's Disease Therapeutics Production Growth by Type (2014-2019)
6 Global Huntington's Disease Therapeutics Market Analysis by Applications
- 6.1 Global Huntington's Disease Therapeutics Consumption Market Share by Application (2014-2019)
- 6.2 Global Huntington's Disease Therapeutics Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Huntington's Disease Therapeutics Business
- 7.1 F. Hoffmann-La Roche
- 7.1.1 F. Hoffmann-La Roche Huntington's Disease Therapeutics Production Sites and Area Served
- 7.1.2 Huntington's Disease Therapeutics Product Introduction, Application and Specification
- 7.1.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 H. Lundbeck
- 7.2.1 H. Lundbeck Huntington's Disease Therapeutics Production Sites and Area Served
- 7.2.2 Huntington's Disease Therapeutics Product Introduction, Application and Specification
- 7.2.3 H. Lundbeck Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Prana Biotechnology
- 7.3.1 Prana Biotechnology Huntington's Disease Therapeutics Production Sites and Area Served
- 7.3.2 Huntington's Disease Therapeutics Product Introduction, Application and Specification
- 7.3.3 Prana Biotechnology Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Teva Pharmaceutical Industries
- 7.4.1 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Production Sites and Area Served
- 7.4.2 Huntington's Disease Therapeutics Product Introduction, Application and Specification
- 7.4.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Horizon Pharma
- 7.5.1 Horizon Pharma Huntington's Disease Therapeutics Production Sites and Area Served
- 7.5.2 Huntington's Disease Therapeutics Product Introduction, Application and Specification
- 7.5.3 Horizon Pharma Huntington's Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
8 Huntington's Disease Therapeutics Manufacturing Cost Analysis
- 8.1 Huntington's Disease Therapeutics Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Huntington's Disease Therapeutics
- 8.4 Huntington's Disease Therapeutics Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Huntington's Disease Therapeutics Distributors List
- 9.3 Huntington's Disease Therapeutics Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Huntington's Disease Therapeutics Market Forecast
- 11.1 Global Huntington's Disease Therapeutics Production, Revenue Forecast
- 11.1.1 Global Huntington's Disease Therapeutics Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Huntington's Disease Therapeutics Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Huntington's Disease Therapeutics Price and Trend Forecast (2019-2025)
- 11.2 Global Huntington's Disease Therapeutics Production Forecast by Regions (2019-2025)
- 11.2.1 North America Huntington's Disease Therapeutics Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Huntington's Disease Therapeutics Production, Revenue Forecast (2019-2025)
- 11.2.3 China Huntington's Disease Therapeutics Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Huntington's Disease Therapeutics Production, Revenue Forecast (2019-2025)
- 11.3 Global Huntington's Disease Therapeutics Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Huntington's Disease Therapeutics Consumption Forecast (2019-2025)
- 11.3.2 Europe Huntington's Disease Therapeutics Consumption Forecast (2019-2025)
- 11.3.3 China Huntington's Disease Therapeutics Consumption Forecast (2019-2025)
- 11.3.4 Japan Huntington's Disease Therapeutics Consumption Forecast (2019-2025)
- 11.4 Global Huntington's Disease Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Huntington's Disease Therapeutics Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Huntington's Disease Therapeutics . Industry analysis & Market Report on Huntington's Disease Therapeutics is a syndicated market report, published as Global Huntington's Disease Therapeutics Market Research Report 2019. It is complete Research Study and Industry Analysis of Huntington's Disease Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
